Consequences of intrathymic TCR engagement by partial agonist on selection events and peripheral T cell activation program

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 4810-4821

  Auphan, Nathalie ^a,c   Simon, Anna Katharina ^a   Asnagli, Hélène ^a   Phillips, Roderick J ^b   Rincon, Mercedes ^b   Ghosh, Sankar ^b   Flavell, Richard A ^b   Schimtt Verhulst, Anne Marie ^a  

^a CNRS   (France)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE REARRANGEMENT; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSACTIVATION;

ANIMALS; ANTIGENS, CD8; CELL DIFFERENTIATION; CELL MOVEMENT; H-2 ANTIGENS; HEMATOPOIETIC STEM CELLS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

EID: 0032525026     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides, Cell 44:959.
2. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An αβT cell receptor structure at 2.5Å and its orientation in the TCR-MHC complex. Science 274:209.
3. Jameson, S. C., and M. J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity 2:1.
4. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation; molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
5. Renard, V., P. Romero, E. Vivier, B. Malissen, and I. Luescher. 1996. CD8β increases CD8 coreceptor function and participation in TCR-ligand binding, J. Exp. Med. 184:2439.
6. Madrenas, J., L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/ partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185:219.
7. Valitutti, S., S. Müller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
8. + T cells. J. Exp. Med. 186:757.
9. Tanaka, Y., L. Ardouin, A. Gillet, S.-Y. Lin, A. Magnan, B. Malissen, and M. Malissen. 1995. Early T-cell development in CD3-deficient mice. Immunol. Rev. 148:171.
10. Fehling, H. J., and H. von Boehmer. 1997. Early αβ T cell development in the thymus of normal and genetically altered mice. Curr. Opin. Immunol. 9:263.
11. Huesmann, M., B. Scott, P. Kisielow, and H. von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66:533.
12. +) thymocytes in normal and genetically modified mice. J. Immunol. 154:5103.
13. Guimezanes, A., T. N. M. Schumacher, H. L. Ploegh, and A.-M. Schmitt-Verhulst. 1992. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product. Eur. J. Immunol. 22.1651.
14. + T cells both trigger CD4/CD8-shared and CD4-unique functions. J. Immunol. 158:4533.
15. + T cells selected by specific class I MHC antigen. Immunity 3:427.
16. Auphan, N., J. Curnow, A. Guimezanes, C. Langlet, B. Malissen, A. Mellor, and A.-M. Schmitt-Verhulst. 1994. The degree of CD8 dependence of cytolytic T cell precursors is determined by the nature of the TCR and influences negative selection in TCR-transgenic mice. Eur. J. Immunol. 24:1572.
17. Rincon, M., and R. A. Flavell. 1994. AP-1 transcriptional activity requires both T-cel) receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13:4370.
18. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956.
19. Buferne, M., F. Luton, F. Letourneur, A. Hoeveler, D. Couez, M. Barad, B. Malissen, A.-M. Schmitt-Verhulst, and C. Boyer. 1992. Role of CD3δ in surface expression of the T cell antigen receptor/CD3 complex and in activation for killing analyzed with CD3δ negative cytolytic T lymphocyte variant. J. Immunol. 148:657.
20. Golstein, P., C. Goridis, A.-M. Schmitt-Verhulst, B. Hayot, A. Pierres, A. Van Agthoven, Y. Kaufmann, Z. Eshhar, and M. Pierres. 1982. Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies. Immunol. Rev. 68:5.
21. Guimezanes, A., and A.-M. Schmitt-Verhulst. 1990. Conditions of Lyt-2-mediated inhibition of TcR/CD3-induced γ-IFN secretion by a CTL clone. Cell. Immunol. 127:187.
22. b-specific TCR transgenic mice expressing mutant H-2Kb: conversion of helper-independent lo helper-dependent CTL. Int. Immunol. 4:1419.
23. + thymocytes in vitro. J. Exp. Med. 179:2027.
24. Jenkinson, E. J., G. Anderson, and J. J. T. Owen. 1992. Studies on T cell maturation on defined thymic stromal cell populations in vitro. J. Exp. Med. 176:845.
25. van Bleek, G. M., and S. G. Nathenson. 1991. The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides. Proc. Natl. Acad. Sci. 88:11032.
26. Cai, Z., and J. Sprent. 1994. Resting and activated T cells display different requirements for CD8 molecules. J. Exp. Med. 179:2005.
27. Blok, R., D. H. Margulies, L. Pease, R. K. Ribaudo, J. Schneck, and J. McCluskey. 1992. CD8 expression alters the fine specificity of an alloreactive MHC class I-specific T hybridoma. Int. Immunol. 4:455.
28. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373:353.
29. Garcia, K. C., C. A. Scott, A. Brunmark, F. R. Carbone, P. A. Peterson, I. A. Wilson, and L. Teyton. 1996. CD8 enhances formation of T cell-receptor/ MHC class I molecule complexes. Nature 384:577.
30. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387:630.
31. Gaugler, B., A.-M. Schmitt-Verhulst, and A. Guimezanes. 1993. Evaluation of functional heterogeneity in the CD8 subset with T cells from TCR-transgenic mice. Eur. J. Immunol. 23:1851.
32. Esser, M. T., B. Krishnamurthy, and V. L. Braciale. 1996. Distinct T cell receptor signaling requirements for perforin- or FasL-mediated cytotoxicity. J. Exp. Med. 183:1697.
33. + T cells by a self-derived peptide. Nature 378:295.
34. Brossart, P., and M. J. Bevan. 1996. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J. Exp. Med. 183:2449.
35. Curnow, S. J., A. Guimezanes, and A.-M. Schmitt-Verhulst. 1994. CD8 requirements for negative selection events are directly related to the TCR-antigen interaction. Thymus 22:255.
36. Hogquist, K. A., A. J. Tomlinson, W. C. Kieper, M. A. McGargill, M. C. Hart, S. Naylor, and S. C. Jameson. 1997. Identification of a naturally occurring ligand for thymic positive selection. Immunity 6:389.
37. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651.
38. Sebzda, E., V. A. Wallace, J. Mayer, R. S. M. Yeung, T. W. Mak, and P. S. Ohashi. 1994. Positive and negative thymocytc selection induced by different concentrations of a single peptide. Science 263:1615.
39. + T cells. Immunity 3:79.
40. Williams, O., Y. Tanaka, R. Tarazona, and D. Kioussis. 1997. The agonist-antagonist balance in positive selection. Immunol. Today 18:121.
41. Buer, J., I. Aifantis, J. P. DiSanto, H. J. Fehling, and H. von Boehmer. 1997. Role of different T cell receptors in the development of pre-T cells. J. Exp. Med. 185:1541.
42. Wilson, A., W. Held, and H. R. MacDonald. 1994. Two waves of recombinase gene expression in developing thymocytes. J. Exp. Med. 179:1355.
43. + cells. Science 258:653.
44. Moebius, U., G. Kober, A. L. Griscelli, T. Hercend, and S. Meuer. 1991. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. Eur. J. Immunol. 21:1793.
45. Guy-Grand, D., B. Rocha, P. Mintz, M. Malassis-Seris, F. Selz, B. Malissen, and P. Vassalli. 1994. Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J. Exp. Med. 180:673.
46. lck correlates with impaired function in vitro and lack of expression in vivo. Nature 342:278.
47. von Boehmer, H., J. Kirberg, and B. Rocha. 1991. An unusual lineage of α/β T cells that contains autoreactive cells. J. Exp. Med. 174:1001.
48. Bruno, L., H. J. Fehling, and H. von Boehmer. 1996. The alpha beta T cell receptor can replace the gamma delta receptor in the development of gamma delta lineage cells. Immunity 5:343.
49. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136.
50. + double-positive stage. J. Exp. Med. 184:1619.
51. Rang, S.-M., B. Beverly, A.-C. Tran, K. Brorson, R. H. Schwartz, and M. J. Lenardo. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134.
52. Schwartz, R. H. 1997. T cell clonal anergy. Curr. Opin. Immunol. 9:351.
53. + T cells. Science 271:1276.
54. + cells. Science 271:1272.
55. Mondino, A., C. D. Whaley, D. R. DeSilva, W. Li, M. K. Jenkins, and D. L. Mueller. 1996. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157:2048.
56. Aune, T. M., L. A. Penix, M. R. Rincon, and R. A. Flavell. 1997. Differential transcription directed by discrete gamma interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells. Mol. Cell. Biol. 17:199.
57. Loftus, D., C. Castelli, T. Clat, P. Squarcina, F. Marincola, M. Nishimura, G. Parmiani, E. Appella, and L. Rivoltini. 1996. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35). J. Exp. Med. 184:647.